Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided Botulinum Toxin for Cricopharyngeal Achalasia
NCT06271395Recruiting
- Start
- Feb 2024
- Primary completion
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in cricopharyngeal achalasia. Primary endpoint: Functional Oral Intake Scale at day 169. Started Feb 2024; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cricopharyngeal achalasia
Beyond the preview
Go deeper on NCT06271395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06271395.